We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
This chapter focuses on the various etiologies for intracerebral hemorrhage (CH), ischemic stroke (IS), transient ischemic attack (TIA), and cerebral venous sinus thrombosis (CVST) that are caused by blood disorders. Bleeding disorders may be inherited or acquired. They include thrombocytopenia and platelet function disorders, coagulation factor deficiencies, excessive anticoagulation and hemorrhagic complications after thrombolysis. Blood disorders associated with myeloproliferative diseases and disseminated intravascular coagulation (DIC) can cause both bleeding and thrombosis. Heparin-induced thrombocytopenia (HIT), the anti-phospholipid antibody syndrome, and thrombotic thrombocytopenic purpura (TTP) are conditions that cause thrombocytopenia but are more frequently responsible for thrombosis than for bleeding. Blood transfusion therapy is recommended as the most important intervention for primary stroke prevention and secondary stroke prevention in children with sickle cell disease. Cytoreduction with hydroxyurea reduces the incidence of thrombosis in essential thrombocythemia, and aspirin reduces the incidence of thrombotic events in polycythemia vera.
Excessive or abnormal vaginal bleeding are the most common symptoms when women present to a gynaecologist. Undiagnosed bleeding disorders, especially Von Willebrand's disorder, can be the under-lying cause of menorrhagia in a significant proportion of women. This chapter aims to increase awareness and provide basic information about these relatively uncommon disorders. Immune idiopathic thrombocytopenic purpura (lTP) in adults is usually a chronic disorder with an insidious onset of minor bleeding symptoms. Menorrhagia and dysmenorrhoea adversely affect women's quality of life and may have a major influence on lifestyle and employment. DDAVP (1-desamino-8-D-arginine vasopressin) nasal spray increases von Willebrand factor (VWF) and FVIII and can be used as a home treatment for some women with bleeding disorders. Increased awareness among clinicians of these problems and the treatment options available are essential to improve quality of life and avoid unnecessary surgical intervention.
Recommend this
Email your librarian or administrator to recommend adding this to your organisation's collection.